Close

Maxim Group Starts Monopar Therapeutics (MNPR) at Buy

September 24, 2020 7:41 AM EDT Send to a Friend
Maxim Group initiates coverage on Monopar Therapeutics (NASDAQ: MNPR) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login